Limb-shaking transient ischemic attack induced by middle cerebral artery stenosis.

421 Dr. V. Puetz, Department of Neurology Technical University Dresden, Fetscherstrasse 74 DE–01307 Dresden (Germany) Tel. +49 351 458 3565, Fax +49 351 458 4365 E-Mail [email protected] 9 Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S; DIAS Study Group: The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005; 36: 66–73. 10 Abciximab in acute ischemic stroke: a randomized, double-blind, placebocontrolled, dose escalation study. The Abciximab in Ischemic Stroke Investigators. Stroke 2000; 31: 601–609. 11 Lapchak PA, Araujo DM: Therapeutic potential of platelet glyocoprotein IIb/IIIa receptor antagonists in the management of ischemic stroke. Am J Cardiovasc Drugs 2003; 3: 87–94. 12 Selim M, Kumar S, Fink J, Schlaug G, Caplan LR, Linfante I: Seizure at stroke onset: should it be an absolute contraindication to thrombolysis? Cerebrovasc Dis 2002; 14: 54–57. 13 Yasaka M, Yamaguchi T, Yonehara T, Moriyasu H: Recurrent embolization during intravenous administration of tissue plasminogen activator in acute ischemic stroke. A case report. Angiology 1994; 45: 481–484. 14 Bautista RED: Embolic stroke following thrombolytic therapy for myocardial infarction in a patient with preexisting ventricular thrombi. Stroke 1995; 26: 324–325. 15 Derex L, Nighoghossian N, Perinetti M, Honnorat J, Trouillas P: Thrombolytic therapy in acute ischemic stroke patients with cardiac thrombus. Neurology 2001; 57: 2122–2125.